Ampullary and pancreatic adenocarcinoma—a comparative study
Author(s) -
Marwa Ferchichi,
Raja Jouini,
Wafa Koubâa,
Fatma Khanchel,
Imen Helal,
Dhafer Hadad,
N Bibani,
Aschraf ChadliDebbiche,
Ehsen BenBrahim
Publication year - 2019
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2018.09.09
Subject(s) - kras , medicine , neuroblastoma ras viral oncogene homolog , pathogenesis , pancreatic cancer , perineural invasion , stage (stratigraphy) , adenocarcinoma , oncology , gastroenterology , pancreatic ductal adenocarcinoma , colorectal cancer , cancer , pathology , cancer research , biology , paleontology
Pancreatic ductal adenocarcinoma (PDAC) and ampullary adenocarcinoma (AAC) are 2 gastrointestinal cancers that share overlapping symptoms. Although some studies have proposed the hypothesis of differences in pathogenesis and prognosis in these 2 cancers; they remain treated similarly. The classification of AAC into three subtypes [pancreatobiliary (PB), intestinal (IT) and mixed (M)] is especially crucial for the 3 axes of patients management (diagnosis, prognosis and therapy). Some studies suggest that PB subtype pathogenesis is comparable to PDAC. The objective of this study was to conduct a comparative analysis between PDAC and AAC; notably PB subtype; via mutational status analysis of 3 oncogenes (KRAS, NRAS and BRAF) hoping to consolidate AAC biology understanding.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom